1. Home
  2. WIMI vs MDXH Comparison

WIMI vs MDXH Comparison

Compare WIMI & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WiMi Hologram Cloud Inc.

WIMI

WiMi Hologram Cloud Inc.

HOLD

Current Price

$2.64

Market Cap

37.4M

Sector

Technology

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$3.41

Market Cap

167.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
WIMI
MDXH
Founded
2015
2003
Country
China
Belgium
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
37.4M
167.8M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
WIMI
MDXH
Price
$2.64
$3.41
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
70.6K
112.3K
Earning Date
12-26-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.43
N/A
Revenue
$61,329,146.00
$103,069,000.00
Revenue This Year
N/A
$23.34
Revenue Next Year
N/A
$22.98
P/E Ratio
$1.85
N/A
Revenue Growth
N/A
21.68
52 Week Low
$2.24
$1.35
52 Week High
$9.66
$5.33

Technical Indicators

Market Signals
Indicator
WIMI
MDXH
Relative Strength Index (RSI) 34.86 45.71
Support Level $2.70 $3.11
Resistance Level $3.07 $3.58
Average True Range (ATR) 0.18 0.17
MACD -0.01 0.04
Stochastic Oscillator 10.14 57.66

Price Performance

Historical Comparison
WIMI
MDXH

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: